Aurinia Pharmaceuticals Inc. (AUPH) Gross margin 2019–2025
Aurinia Pharmaceuticals Inc. (AUPH) gross margin by fiscal year — reported gross profit divided by reported revenue.
88.5%FY2025 · since FY2019: 100.0% → 88.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 88.5% | +0.5 pp |
| FY2024 | 88.0% | -4.0 pp |
| FY2023 | 91.9% | -3.8 pp |
| FY2022 | 95.8% | -1.8 pp |
| FY2021 | 97.6% | -2.4 pp |
| FY2020 | 100.0% | +0.0 pp |
| FY2019 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →